Search Within

Department of Medicine

Formats
  1. Journal Article (19582)
  2. Meeting Abstract (16038)
  3. Review (1149)
  4. Book Section (934)
  5. Editorial (607)
  6. Research Letter (314)
  7. Conference Paper (301)
  8. Guidelines (295)
  9. Correspondence (235)
  10. Miscellaneous (90)
  11. Book Whole (61)
Groups
  1. Solid Tumor Oncology Division (22315)
  2. Hematologic Malignancies, Division of (13270)
  3. Center for Hematologic Malignancies (11055)
  4. GSK Faculty (10643)
  5. Survivorship Research (9327)
  6. Division of Subspecialty Medicine (7533)

More Groups

People
  1. Robert Motzer (1248)
  2. Howard Scher (1132)
  3. Sergio Giralt (1068)
  4. Miguel-Angel Perales (943)
  5. Clifford Hudis (905)
  6. Jedd Wolchok (905)

More People

Years
  1. 2025 (1055)
  2. 2024 (2291)
  3. 2023 (2452)
  4. 2022 (2621)
  5. 2021 (2534)
  6. 2020 (2563)

More Years

Publications
  1. Journal of Clinical Oncology (6125)
  2. Blood (3722)
  3. Annals of Oncology (1398)
  4. Cancer Research (1238)
  5. Clinical Cancer Research (902)
  6. Biology of Blood and Marrow Transplantation (679)

More Publications

Publishers
  1. American Society of Clinical Oncology (6457)
  2. Elsevier Inc. (4215)
  3. American Society of Hematology (4001)
  4. American Association for Cancer Research (2896)
  5. Oxford University Press (2286)
  6. Nature Publishing Group (2110)

More Publishers

Results (39606)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Connections across the Cancer Continuum
    Editorial

    Diaz, L. A.; Cantley, L. C.
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Nonselective β-adrenergic receptor inhibitors impair hematopoietic regeneration in mice and humans after hematopoietic cell transplants
    Journal Article

    Nishino, J.; Hu, W.; Kishtagari, A.; Shen, B.; Gao, X.; Blackman, C. M.; Kassim, A.; Marneni, N.; Cherukuri, A. V.; Vittrup, R.; more...
    Cancer Discovery (2025)

    Fulltext@MSK | Save
  • From knowledge to action: The journey toward targeting the MET pathway via MET exon 14 skipping
    Review

    Bogdanska, W.; Paik, P. K.
    Cancer (2025)

    Fulltext@MSK | Save
  • Targeting ROS1 rearrangements in non–small cell lung cancer: Current insights and future directions
    Review

    Desilets, A.; Repetto, M.; Yang, S. R.; Drilon, A.
    Cancer (2025)

    Fulltext@MSK | Save
  • Correlation analysis of invasive disease-free survival and overall survival in a real-world population of patients with HR+/HER2– early breast cancer
    Journal Article

    Graff, S. L.; Tolaney, S. M.; Hart, L. L.; Razavi, P.; Janni, W.; Schwartzberg, L. S.; Danyliv, A.; Akdere, M.; Ferrusi, I.; Adhikary, R. R.; more...
    Cancer (2025)

    Fulltext@MSK | Save
  • Pregnancy-specific glycoproteins as potential drug targets for female lung adenocarcinoma patients
    Journal Article

    Oh, J. H.; Rizzuto, G.; Elkin, R.; Weistuch, C.; Norton, L.; Dveksler, G.; Deasy, J. O.
    Briefings in Functional Genomics (2025)

    Fulltext@MSK | Save
  • Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies
    Review

    Reinhorn, D.; Moskovitz, M.; Tap, W. D.; Li, B. T.
    Cancer (2025)

    Fulltext@MSK | Save
  • Impact of gross extrathyroidal extension to the recurrent laryngeal nerve alone on survival in papillary thyroid carcinoma
    Journal Article

    Harries, V.; Scholfield, D. W.; Eagan, A.; Tuttle, R. M.; Shaha, A. R.; Shah, J. P.; Wong, R. J.; Patel, S. G.; Ganly, I.
    British Journal of Surgery (2025)

    Fulltext@MSK | Save
  • Impact of adding palbociclib on treatment adherence to ongoing adjuvant endocrine treatment in the global randomized PALLAS randomized trial in patients with early breast cancer
    Journal Article

    Shinn, E.; Zahrieh, D.; DeMichele, A.; Zdenkowski, N.; Lemieux, J.; Mao, J.; Bjelic-Radisic, V.; Naughton, M. J.; Pfeiler, G.; Gelmon, K.; more...
    Breast Cancer Research and Treatment (2025)

    Fulltext@MSK | Save
  • Real-world risk of recurrence and treatment outcomes with adjuvant endocrine therapy in patients with stage II-III HR+/HER2- early breast cancer
    Journal Article

    O'Shaughnessy, J.; Tolaney, S. M.; Yardley, D. A.; Hart, L.; Razavi, P.; Fasching, P. A.; Janni, W.; Schwartzberg, L.; Kim, J.; Akdere, M.; more...
    Breast (2025)

    Fulltext@MSK | Save